本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNexus Gene Lab Corp.

2.72
+0.03001.12%
成交量:3.01万
成交额:8.23万
市值:488.67万
市盈率:-5.13
高:2.85
开:2.69
低:2.65
收:2.69
数据加载中...
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/31

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/31

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/24

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/04/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/26

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/17

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K/A - Current report: [Amend]